DOI: 10.1001/jama.2023.26504 ISSN: 0098-7484
Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis
Maya N. Faison, Andrew M. Davis, Kimberly C. Trotter- General Medicine
This article summarizes a 2022 clinical practice guideline on the use of disease-modifying antirheumatic drugs (DMARDs) for adults with rheumatoid arthritis from the European League Against Rheumatism (EULAR).